| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/20/2001 | WO2001068044A1 Oral composition comprising 2'-hydroxypropiophenone |
| 09/20/2001 | WO2001068040A2 The use of plant extracts and sugars to protect keratinous tissue |
| 09/20/2001 | WO2001068034A2 1, 2, 4-triazoloribonucleoside prodrugs and their administration to treat viral disease conditions |
| 09/20/2001 | WO2001068033A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001067896A2 Method of producing oily suspensions of water-soluble vitamins |
| 09/20/2001 | WO2001067895A1 Carbohydrate system and a method for providing nutriton to a diabetic |
| 09/20/2001 | WO2001067890A2 Composition and method to treat weight gain and obesity attributable to psychotropic drugs |
| 09/20/2001 | WO2001067889A1 Diabetic nutritionals |
| 09/20/2001 | WO2001041567A8 Deep penetrating antimicrobial compositions |
| 09/20/2001 | WO2001034591A3 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/20/2001 | WO2001032180A3 Composition for treatment of constipation and irritable bowel syndrome |
| 09/20/2001 | WO2001032029A3 Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein |
| 09/20/2001 | WO2001030379A3 Compositions and methods for preventing and treating transplant rejection |
| 09/20/2001 | WO2001030316A3 Transdermal drug delivery devices comprising (r)-(z)-1-azabicyclo(2.2.1)heptan-3-one, 0-(3(3-methoxyphenyl)-2-propynyl)oxime |
| 09/20/2001 | WO2001029070A8 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 09/20/2001 | WO2001028579A3 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 09/20/2001 | WO2001028533A3 PRODUCTS AND METHODS FOR ACTIVATING PPARη-RXR AND UP-REGULATING MONOCYTE/MACROPHAGE CD36 FOR THE TREATMENT OF MALARIA |
| 09/20/2001 | WO2001027118A3 Bicyclic imidazo-5-yl-amine derivatives |
| 09/20/2001 | WO2001027110A3 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring |
| 09/20/2001 | WO2001027109A3 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 09/20/2001 | WO2001019819A3 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/20/2001 | WO2001018025A3 17alpha propynyl 11-aryl steroids |
| 09/20/2001 | WO2001017513A3 Pharmaceutical composition comprising an insulin sensitizer |
| 09/20/2001 | WO2001017479A3 Methods and compositions for preventing and treating prostate disorders |
| 09/20/2001 | WO2001015675A3 Use of docetaxel for treating hepatocellular carcinoma |
| 09/20/2001 | WO2001015664A3 Coformulation methods and their products |
| 09/20/2001 | WO2001013953A3 Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist |
| 09/20/2001 | WO2001013887A3 Phospholipin gel |
| 09/20/2001 | WO2001012167A3 Pharmaceutical compositions comprising a 7-(2-aminoethyl)-benzothiazolone and an anticholinergic muscarinic antagonist |
| 09/20/2001 | WO2001010427A3 Use of anti-muscarinic agents for treating skin disorders |
| 09/20/2001 | WO2000071506A9 Naphthalene ureas as glucose uptake enhancers |
| 09/20/2001 | WO2000047583A9 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 09/20/2001 | WO2000047553A8 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
| 09/20/2001 | WO2000046246A8 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 09/20/2001 | WO2000044774A9 Inhibition of stat3 signal transduction for human cancer therapy |
| 09/20/2001 | WO2000037490A3 Outer surface proteins, their genes, and their use |
| 09/20/2001 | WO2000037066A3 A method for the prophylactic treatment of cataracts |
| 09/20/2001 | WO2000028945A3 Anticonvulsant derivatives useful in treating post traumatic stress disorder |
| 09/20/2001 | WO2000027378A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | WO2000024419A9 Methods for enhancing wound healing |
| 09/20/2001 | US20010023349 Hypodermic needle with weeping tip and method of use |
| 09/20/2001 | US20010023293 2-hydroxyphenyl benzotriazoles as uv-a/b filters |
| 09/20/2001 | US20010023292 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4 -(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine, for example |
| 09/20/2001 | US20010023291 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 09/20/2001 | US20010023260 Method for preventing and treating peripheral neuropathy by administering selegiline |
| 09/20/2001 | US20010023259 Nutrients, drugs |
| 09/20/2001 | US20010023258 Mixture with carbonic anhydrase inhibitor |
| 09/20/2001 | US20010023257 Hypotensive agents; anticholesterol agents |
| 09/20/2001 | US20010023256 Reducing concentration of oxygen metabolites |
| 09/20/2001 | US20010023254 Use of sulfamate derivatives for treating impulse control disorders |
| 09/20/2001 | US20010023253 Novel compound |
| 09/20/2001 | US20010023252 Paroxetine methanesulfonate |
| 09/20/2001 | US20010023251 Guanidine derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 09/20/2001 | US20010023250 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 09/20/2001 | US20010023246 Drug and pharmaceutical composition for the treatment of lesions of the nervous system and fractions enriched in heparan sulfate |
| 09/20/2001 | US20010023240 Compounds and compositions for delivering active agents |
| 09/20/2001 | US20010022979 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 09/20/2001 | US20010022978 Therapy for sensitive skin |
| 09/20/2001 | US20010022975 Topical gel; containing vasodilator |
| 09/20/2001 | US20010022973 Pharmaceutical composition for piperidinoalkanol compounds |
| 09/20/2001 | US20010022970 Halogenated xanthan compound |
| 09/20/2001 | US20010022965 Colloidal dispersion |
| 09/20/2001 | US20010022964 Fast dissolving orally consumable films |
| 09/20/2001 | US20010022962 Cellulose diacetate compositions for use in embolizing blood vessels |
| 09/20/2001 | EP1143960A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | DE10013578A1 Use of 3,4-dihydroxymandelic acid and/or stereoisomers as antioxidants and/or radical scavengers in protecting mammalian skin, cosmetic or pharmaceutical preparations, foodstuffs, lacquers and polymers |
| 09/20/2001 | DE10013318A1 Quinoxaline derivatives are used as photo-stable UV filters in cosmetic or pharmaceutical sunscreens for the hair or skin |
| 09/20/2001 | DE10013312A1 Production of oily suspensions of water soluble vitamins comprises milling of vitamins in oil or dry milling and suspension in oil |
| 09/20/2001 | DE10013306A1 New indeno-dihydrothiazole, naphtho-dihydrothiazole and benzocyclohepta-dihydrothiazole derivatives useful as anorectic agents in the treatment and prevention of obesity and type II diabetes |
| 09/20/2001 | DE10013167A1 Cosmetic or dermatological skin treatment composition containing ascorbic acid or derivative, stabilized by combination of polyphenol, lipophilic antioxidant and basic nitrogen compound |
| 09/20/2001 | DE10013156A1 Water-containing vehicle for cosmetic or dermatological compositions, in which active agents or auxiliaries are stabilized by combination of ascorbic acid or derivative, polyphenol and buffer |
| 09/20/2001 | DE10013029A1 Multilayer formulation for controlled drug release in colon, comprising drug-containing core having inner and outer coatings of acrylic copolymers with quaternary ammonium and anionic groups respectively |
| 09/20/2001 | DE10012413A1 Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 4,4'-Diarylbutadiene enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen Use of sunscreen combinations which comprise as an essential ingredient 4,4'-diarylbutadienes as photostable UV filters in cosmetic and pharmaceutical preparations |
| 09/20/2001 | DE10012373A1 Treating erectile dysfunction using new or known imidazo(1,5-a)pyrido(3,2-e)pyrazinone derivatives, as cGMP-selective phosphodiesterase V inhibitors free of cardiovascular side-effects |
| 09/20/2001 | DE10012259A1 Antiviral combination based on dihydropyrimidine derivatives and non-dihydropyrimidine HBV antiviral agents, are useful for treatment of HBV infections |
| 09/20/2001 | DE10012026A1 Stable aqueous gel containing polyhexamethylene biguanide, glycerol and hydroxyethyl cellulose, useful e.g. as washing or shower gel having decontaminant action or for covering wounds, |
| 09/20/2001 | DE10011541A1 Water additive for increasing vitality of bony fish, comprising combination of ephedrine and caffeine and/or theophylline, especially useful for combating transport stress |
| 09/20/2001 | CA2411732A1 Crystalline base of citalopram |
| 09/20/2001 | CA2403679A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2403442A1 Use of nateglinide alone or in combination for the treatment or prevention of diabetic complications |
| 09/20/2001 | CA2403420A1 Compounds capable of binding with the cytoskeleton |
| 09/20/2001 | CA2403393A1 Methods and compositions for immunoregulation |
| 09/20/2001 | CA2403358A1 Antiviral therapy |
| 09/20/2001 | CA2403350A1 Use of deramciclane for the treatment of anxiety and depression |
| 09/20/2001 | CA2403252A1 Neutral antagonists and use thereof in treating drug abuse |
| 09/20/2001 | CA2403241A1 Pharmaceutical compositions of glycogen phosphorylase inhibitors |
| 09/20/2001 | CA2403233A1 Glycogen phosphorylase inhibitor |
| 09/20/2001 | CA2403220A1 Methods and compositions for the regulation of vasoconstriction |
| 09/20/2001 | CA2403205A1 Compositions and methods of regulated protein expression in gut endocrine k cells |
| 09/20/2001 | CA2403188A1 Pyridazinyl phenyl hydrazones useful against congestive heart failure |
| 09/20/2001 | CA2403149A1 2-phenylpyran-4-one derivatives |
| 09/20/2001 | CA2403109A1 Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 09/20/2001 | CA2403084A1 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 09/20/2001 | CA2403063A1 Polysaccharidic esters of n-derivatives of glutamic acid |
| 09/20/2001 | CA2403062A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2403017A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | CA2402908A1 Assay for agents that induce chemokinesis |
| 09/20/2001 | CA2402898A1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 09/20/2001 | CA2402891A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2402869A1 Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |